|
|
|
|
LEADER |
01816nam a22003615i 4500 |
001 |
000281343 |
005 |
20210722135733.0 |
007 |
cr nn 008mamaa |
008 |
161012s2016 si | s |||| 0|eng d |
020 |
|
|
|a 9789811020414
|
024 |
7 |
|
|a 10.1007/978-981-10-2041-4
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Cystogenesis /
|c edited by Jong Hoon Park, Curie Ahn.
|
250 |
|
|
|a 1st ed. 2016.
|
260 |
# |
# |
|a Singapore :
|b Springer Singapore :
|b Imprint: Springer,
|c 2016.
|
300 |
|
|
|a IX, 126 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 933
|
505 |
0 |
|
|a Part I ADPKD Overview -- Chapter 1 Recent Trends in ADPKD Research -- Chapter 2 Genetic Mechanisms of ADPKD -- Part II Cystogenesis Mechanisms -- Chapter 3 Cell Proliferation and Apoptosis in ADPKD -- Chapter 4 Inflammation and Fibrosis in ADPKD -- Chapter 5 Functional Study of the Primary Cilia in ADPKD -- Chapter 6 Epigenetic Regulation in Cystogenesis -- Part III Therapeutic Approaches and Diagnostic Markers for ADPKD -- Chapter 7 Validation of Effective Therapeutic Targets for ADPKD using Animal Models -- Chapter 8 Diagnostic Evaluation as a Biomarker in Patients with ADPKD -- Chapter 9 Clinical Trials and a View toward the Future of ADPKD.
|
650 |
|
0 |
|a Human genetics.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
|
0 |
|a Cell biology.
|
650 |
|
0 |
|a Medical microbiology.
|
650 |
1 |
4 |
|a Human Genetics.
|
650 |
2 |
4 |
|a Molecular Medicine.
|
650 |
2 |
4 |
|a Cell Biology.
|
650 |
2 |
4 |
|a Medical Microbiology.
|
700 |
1 |
|
|a Park, Jong Hoon.
|e editor.
|
700 |
1 |
|
|a Ahn, Curie.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|